FDA Inspection
BioLife Plasma Services LPBioLife Plasma Services LP – FDA Inspection, Jul 30, 2013
Record Details
This FDA Inspection record concerns BioLife Plasma Services LP, with an inspection on July 30, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- BioLife Plasma Services LP
- Inspection Date
- July 30, 2013
- Product Type
- Biologics
View Company Profile
ID · 8387f70f-d0d0-4991-bfa0-4169eaa7b954
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 833294
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.100(c)Thorough investigations
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of BioLife Plasma Services LP
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 26, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 29, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 12, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 6, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for BioLife Plasma Services LP
- FDA Inspection 1067223 - 2018-09-26
- FDA Inspection 950080 - 2015-10-29
- FDA Inspection 882946 - 2014-06-12
- FDA Inspection 719309 - 2011-04-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.